{
    "clinical_study": {
        "@rank": "143110", 
        "acronym": "FUSE", 
        "arm_group": {
            "arm_group_label": "Endoscopy exploratory single arm", 
            "arm_group_type": "Experimental", 
            "description": "Exploratory single arm, the system will be used in otherwise standard procedures, and will be reviewed in terms of performance, usability, ease of use and safety."
        }, 
        "brief_summary": {
            "textblock": "EndoChoice's FUSE System enables a wider view range via 1-2 additional cameras (depending on\n      the model). These optical properties are to be examined and reviewed in this trial (mainly\n      usability and safety)"
        }, 
        "brief_title": "A Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing a Full Spectrum Optical Technology", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastrointestinal Diseases", 
        "condition_browse": {
            "mesh_term": [
                "Gastrointestinal Diseases", 
                "Digestive System Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "EndoChoice Full Spectrum Optical Technology (FSOT) in gastrointestinal endoscopy enables a\n      330 degree field of view. FSOT powers EndoChoice's FDA, CE and AMAR (Israeli medical device\n      authority) approved Endoscopic systems (Gastroscope and Colonoscope).  The intent of this\n      study is to evaluate the safety, performance and usability of additional versions of FSOT-\n      powered gastroscopes and colonoscopes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and Female patients ages of 18-70\n\n          -  The patient has been scheduled for routine screening upper or lower endoscopy,\n             diagnostic endoscopic work up, or endoscopic surveillance.\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Patients with inflammatory bowel disease;\n\n          -  Patients with a personal history of polyposis syndrome;\n\n          -  Patients with suspected bowel stricture potentially precluding complete    endoscopy\n\n          -  Patients with a history of diverticulitis or toxic megacolon\n\n          -  Patients with a history of radiation therapy to neck, abdomen, pelvis;\n\n          -  Patients who are currently enrolled in another clinical investigation in which the\n             intervention might compromise the safety of the patient's participation in this\n             study.\n\n          -  Patients with GI bleeding, that has not been corrected prior to endoscopy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "280", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02143284", 
            "org_study_id": "CD-1715"
        }, 
        "intervention": {
            "arm_group_label": "Endoscopy exploratory single arm", 
            "description": "The investigational device will be applied in otherwise standard procedures (upper and lower Gastrointestinal tract endoscopy)", 
            "intervention_name": "Endoscopy exploratory single arm (EndoChoice FUSE(TM) System)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 20, 2014", 
        "location": {
            "contact": {
                "email": "dl_katz@rambam.health.gov.il", 
                "last_name": "Dalia Katz, SSC", 
                "phone": "0097248547777"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel", 
                    "zip": "31096"
                }, 
                "name": "Rambam medical center"
            }, 
            "investigator": {
                "last_name": "Ian Gralnek, Prof.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Single-Center, Exploratory Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing EndoChoice's Full Spectrum Optical Technology", 
        "overall_contact": {
            "email": "i_gralnek@rambam.health.gov.il", 
            "last_name": "Ian Gralnek, Prof.", 
            "phone": "00972502066106"
        }, 
        "overall_official": {
            "affiliation": "Rambam Medical Center Gastroenterological institute", 
            "last_name": "Ian Gralnek, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The performance of the device is assessed via a performance questionnaire which the recruiting (and treatment providing) physician will answer.", 
            "measure": "Performance, usability and ease of use", 
            "safety_issue": "No", 
            "time_frame": "1 Year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02143284"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The safety of the device will be assessed as a secondary outcome measure according to quantity and nature of adverse and severe adverse events, if such occur.", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "1 Year"
        }, 
        "source": "EndoChoice Innovation Center, Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EndoChoice Innovation Center, Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}